Global Eye Health Ingredients Market Overview

Global Eye Health Ingredients Market was valued at USD 364.94 Million in 2021 and is expected to reach USD 552.37 Million by the year 2028, at a CAGR of 6.1%.

The eyes are compounded organs. Many parts must work together to create a clear vision. The growing populations of aging individuals and persons stick to a screen all day, there is an equally rising need for ingredients and products that address eye health. That requirement is even more critical in the view of research revealing that, since the eyes are a direct link to the central nervous system in the brain, eye health put up to overall coherent and emotional health. Furthermore, applications of powerful vitamins, antioxidants, and minerals to your diet can enhance your vision and overall eye health. According to the researchers, eye-friendly nutrients, such as lutein and zeaxanthin, vitamin C, vitamin E, and zinc, to diminishing the risk of certain serious eye diseases such as age-related macular degeneration, cataract, and, dry eye syndrome.  According to, former chief science officer for the Los Angeles County Department of Public Health Mr. Steven Teutsch, it is approximate that about 90 million of the 142 million Americans above age 40 are experiencing vision issues, and this population could twice by 2050.

COVID-19 Impact on Eye Health Ingredients Market

COVID-19 outbreak has become the most significant challenge across the globe. This challenge will be terrifying the countries over the globe as it will lead to reducing imports owing to interruptions in global trade, which further increases the shortages of eye health ingredients, resulting in a considerable price increase. Producers are also experiencing increased prices and potential shortages of raw ingredients owing to supply limitations. However, the eye health ingredients market is significantly gaining its pre-COVID stages and a strong growth rate is anticipated over the forecast period driven by the economic revival in most of the emerging nations. Nevertheless, unrivaled situations owing to anticipated third and further waves are producing a gloomy outlook.

Market Dynamics and Factors

Drivers:

Growing consumer consciousness regarding eye health advantages from carotenoids, zeaxanthin, and lutein continues to grow steadily. Increasing eye supplement introduction numbers will improve the product demand during the forecast period. The eye supplements registered for more than 4% of the world supplement launches in the year 2016. Maintaining strong vision, removing free radicals, and defense from UV radiation are the prime features boosting product penetration.

Additionally, increasing consumer requirements regarding vision nutrition owing to rising age-related eye diseases are the factors, driving eye health ingredients market growth. Rising eye health issues such as diabetic retinopathy, age-related macular degeneration (AMD), cataracts, and glaucoma will escalate industry growth. According to AMD disorder caused cancer in more than 50% of cases in the U.S. Global consumer expenses against AMD treatment was more than USD 200 million in 2015. Moreover, busy lifestyles along with exposure to toxic materials harm the eyesight of people leading to suffering from an unhealthy vision. The growing requirement to maintain the perfect "20/20" eyesight has reduced the demand for eye health ingredients.

Growing consumer spending on nutritional products coupled with regulatory support for OTC supplements has strongly affected industry growth. Industry participants are introducing various dietary supplement types in the market, based on the interest of consumers. Magazines, television, the internet, articles, and ad campaigns are prominent affecting portals to reduce consumer interest in supplements demand.

Restraints:

Adequate accessibility and comparatively high costs may negatively affect the eye health ingredients market price trend. Vision ingredients are highly preferred on prescription owing to the multivitamin content. Poor product utilization causing health issues owing to over-the-counter (OTC) products may restraint the eye health ingredients market growth.

Opportunities:

Research and developments, natural-based ingredients products for the consumers and their awareness, and various mergers, the collaboration of the key players will be expected to create lucrative opportunities for the eye health ingredients market in the upcoming years.

Market Segmentation

Segmentation Insights

Based on Ingredient Type, lutein and zeaxanthin are projected to account for the largest share in the market during the forecast period. Lutein and zeaxanthin are highly used eye health ingredients in the sector. Growing potential usage in formulated supplementary food and infant formula products will improve the lutein market size. They are generally combined with other beneficial health components, which include antioxidant vitamins A, E, C, B (B6 & 12) and blueberry extracts, as a basis of anthocyanins, omega-3 fatty acids, and minerals such as selenium and zinc. Growing demand from the medical and food industry due to its strong efficiency with less concentration will boost the zeaxanthin market size.

Based on Source, the natural source segment is projected to dominate the market over the forecast period. Switching consumer preference to naturally sourced products especially in Europe and North America will improve the natural eye health ingredients market growth. Increasing consumer consciousness towards sufferings from chemically synthesized product utilization will accelerate the demand for its natural counterpart.

Based on Form, capsule & tablets are projected to register the maximum share in the market during the forecast period, owing to its ease in utilization and reducing stomach upset possibility characteristics.

Based on Application, the human application segment is strongly registered the market share. Growing vision issues at an early age such as macular degeneration, cataracts, and glaucoma have influenced product demand in this segment. Rising surgery expenditures is another factor encouraging customers towards OTC supplements to avoid high expenses on hospitals.

Based on Disease Indication, age-related macular degeneration disease is projected to account for the maximum share over the forecast period. The eye health ingredients market is mainly utilized in age-related macular degeneration disease. According to, age-related macular degeneration (AMD) Alliance International, about 26 to 32 million individuals worldwide are suffering from AMD. In addition, the institute also monitored the baby boomers' generation gets older, the cases will increase and triple by 2024. This is owing to rising age, the level of pigment in macula reduces naturally, in that way increasing the risk of AMD.

Regional Insights

North America region is projected to dominate the Eye Health Ingredients Market owing to the growing cases of eye problems and increasing number of launches of new eye health ingredient products in this region. The key causes of blindness and low vision in the United States are mainly age-related eye diseases including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma. More consumer spending on drugs and pharmaceuticals will also boost this eye health ingredients market in the region.

In Europe, the eye health ingredients market is projected to witness high gains during the forecast period. Growing consumer spending on healthcare and medicines will accelerate the regional demand. The country Russia is a major product utilization nation due to its high geriatric population.

Asia Pacific region is projected to account for the significant growth rate for the eye health ingredients market, owing to the region is leading in the overall dietary ingredient sector. Growing disposable income and increasing consumer interest regarding healthy lifestyle particularly in China, Japan and India will boost the regional demand.

Key Industry Developments

• In April 2019, Algatechnologies, Ltd, declared that the introduction of AstaPure-EyeQ, a natural cold water-soluble astaxanthin powder to defense the eye from radiation and oxidative stress.
• In October 2015, DSM and Kemin declared that the introduction of two new products, OPTISHARP Zeaxanthin and FloraGLO Lutein to spread their product portfolio in the vision health solutions market. 

Players Covered in Eye Health Ingredients market are :

• Allied Biotech Corporation (Taiwan)
• Efamol
• MacuShield
• BASF SE (Germany)
• (U.S.)
• AIDP Inc. (U.S.)
• BI Nutraceuticals (U.S.)
• BLUE CALIFORNIA (U.S.)
• Amway
• DSM (The Netherlands)
• Alcon
• Solgar
• Swanson
• FMC Corporation and others.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
 3.3 By Source
 3.4 By Form

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Eye Health Ingredients Market by Type
 5.1 Eye Health Ingredients Market Overview Snapshot and Growth Engine
 5.2 Eye Health Ingredients Market Overview
 5.3 Beta Carotene
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Beta Carotene: Grographic Segmentation
 5.4 Vitamin A
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Vitamin A: Grographic Segmentation
 5.5 Lutein
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Lutein: Grographic Segmentation
 5.6 Zeaxanthin
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Zeaxanthin: Grographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Grographic Segmentation

Chapter 6: Eye Health Ingredients Market by Application
 6.1 Eye Health Ingredients Market Overview Snapshot and Growth Engine
 6.2 Eye Health Ingredients Market Overview
 6.3 Human
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Human: Grographic Segmentation
 6.4 Animal
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Animal: Grographic Segmentation

Chapter 7: Eye Health Ingredients Market by Source
 7.1 Eye Health Ingredients Market Overview Snapshot and Growth Engine
 7.2 Eye Health Ingredients Market Overview
 7.3 Natural
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Natural: Grographic Segmentation
 7.4 Synthetic
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Synthetic: Grographic Segmentation

Chapter 8: Eye Health Ingredients Market by Form
 8.1 Eye Health Ingredients Market Overview Snapshot and Growth Engine
 8.2 Eye Health Ingredients Market Overview
 8.3 Soft Gel
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Soft Gel: Grographic Segmentation
 8.4 Capsule & Tablets
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Capsule & Tablets: Grographic Segmentation
 8.5 Liquid
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Liquid: Grographic Segmentation
 8.6 Powder
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Powder: Grographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Eye Health Ingredients Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Ansoff Matrix
  9.1.5 Eye Health Ingredients Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Eye Health Ingredients Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 ALLIED BIOTECH CORPORATION
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 EFAMOL
 9.4 MACUSHIELD
 9.5 BASF SE
 9.6 AIDP INC.
 9.7 BI NUTRACEUTICALS
 9.8 BLUE CALIFORNIA
 9.9 AMWAY
 9.10 DSM
 9.11 ALCON
 9.12 SOLGAR
 9.13 SWANSON
 9.14 OTHER MAJOR PLAYERS

Chapter 10: Global Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Type
  10.2.1 Beta Carotene
  10.2.2 Vitamin A
  10.2.3 Lutein
  10.2.4 Zeaxanthin
  10.2.5 Others
 10.3 Historic and Forecasted Market Size By Application
  10.3.1 Human
  10.3.2 Animal
 10.4 Historic and Forecasted Market Size By Source
  10.4.1 Natural
  10.4.2 Synthetic
 10.5 Historic and Forecasted Market Size By Form
  10.5.1 Soft Gel
  10.5.2 Capsule & Tablets
  10.5.3 Liquid
  10.5.4 Powder

Chapter 11: North America Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Beta Carotene
  11.4.2 Vitamin A
  11.4.3 Lutein
  11.4.4 Zeaxanthin
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Human
  11.5.2 Animal
 11.6 Historic and Forecasted Market Size By Source
  11.6.1 Natural
  11.6.2 Synthetic
 11.7 Historic and Forecasted Market Size By Form
  11.7.1 Soft Gel
  11.7.2 Capsule & Tablets
  11.7.3 Liquid
  11.7.4 Powder
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Beta Carotene
  12.4.2 Vitamin A
  12.4.3 Lutein
  12.4.4 Zeaxanthin
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Human
  12.5.2 Animal
 12.6 Historic and Forecasted Market Size By Source
  12.6.1 Natural
  12.6.2 Synthetic
 12.7 Historic and Forecasted Market Size By Form
  12.7.1 Soft Gel
  12.7.2 Capsule & Tablets
  12.7.3 Liquid
  12.7.4 Powder
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Beta Carotene
  13.4.2 Vitamin A
  13.4.3 Lutein
  13.4.4 Zeaxanthin
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Human
  13.5.2 Animal
 13.6 Historic and Forecasted Market Size By Source
  13.6.1 Natural
  13.6.2 Synthetic
 13.7 Historic and Forecasted Market Size By Form
  13.7.1 Soft Gel
  13.7.2 Capsule & Tablets
  13.7.3 Liquid
  13.7.4 Powder
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Beta Carotene
  14.4.2 Vitamin A
  14.4.3 Lutein
  14.4.4 Zeaxanthin
  14.4.5 Others
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Human
  14.5.2 Animal
 14.6 Historic and Forecasted Market Size By Source
  14.6.1 Natural
  14.6.2 Synthetic
 14.7 Historic and Forecasted Market Size By Form
  14.7.1 Soft Gel
  14.7.2 Capsule & Tablets
  14.7.3 Liquid
  14.7.4 Powder
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Eye Health Ingredients Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Type
  15.4.1 Beta Carotene
  15.4.2 Vitamin A
  15.4.3 Lutein
  15.4.4 Zeaxanthin
  15.4.5 Others
 15.5 Historic and Forecasted Market Size By Application
  15.5.1 Human
  15.5.2 Animal
 15.6 Historic and Forecasted Market Size By Source
  15.6.1 Natural
  15.6.2 Synthetic
 15.7 Historic and Forecasted Market Size By Form
  15.7.1 Soft Gel
  15.7.2 Capsule & Tablets
  15.7.3 Liquid
  15.7.4 Powder
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EYE HEALTH INGREDIENTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EYE HEALTH INGREDIENTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EYE HEALTH INGREDIENTS MARKET COMPETITIVE RIVALRY
TABLE 005. EYE HEALTH INGREDIENTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. EYE HEALTH INGREDIENTS MARKET THREAT OF SUBSTITUTES
TABLE 007. EYE HEALTH INGREDIENTS MARKET BY TYPE
TABLE 008. BETA CAROTENE MARKET OVERVIEW (2016-2028)
TABLE 009. VITAMIN A MARKET OVERVIEW (2016-2028)
TABLE 010. LUTEIN MARKET OVERVIEW (2016-2028)
TABLE 011. ZEAXANTHIN MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. EYE HEALTH INGREDIENTS MARKET BY APPLICATION
TABLE 014. HUMAN MARKET OVERVIEW (2016-2028)
TABLE 015. ANIMAL MARKET OVERVIEW (2016-2028)
TABLE 016. EYE HEALTH INGREDIENTS MARKET BY SOURCE
TABLE 017. NATURAL MARKET OVERVIEW (2016-2028)
TABLE 018. SYNTHETIC MARKET OVERVIEW (2016-2028)
TABLE 019. EYE HEALTH INGREDIENTS MARKET BY FORM
TABLE 020. SOFT GEL MARKET OVERVIEW (2016-2028)
TABLE 021. CAPSULE & TABLETS MARKET OVERVIEW (2016-2028)
TABLE 022. LIQUID MARKET OVERVIEW (2016-2028)
TABLE 023. POWDER MARKET OVERVIEW (2016-2028)
TABLE 024. NORTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 025. NORTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 026. NORTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 027. NORTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY FORM (2016-2028)
TABLE 028. N EYE HEALTH INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 029. EUROPE EYE HEALTH INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 030. EUROPE EYE HEALTH INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 031. EUROPE EYE HEALTH INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 032. EUROPE EYE HEALTH INGREDIENTS MARKET, BY FORM (2016-2028)
TABLE 033. EYE HEALTH INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 034. ASIA PACIFIC EYE HEALTH INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 035. ASIA PACIFIC EYE HEALTH INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 036. ASIA PACIFIC EYE HEALTH INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 037. ASIA PACIFIC EYE HEALTH INGREDIENTS MARKET, BY FORM (2016-2028)
TABLE 038. EYE HEALTH INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA EYE HEALTH INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA EYE HEALTH INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA EYE HEALTH INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA EYE HEALTH INGREDIENTS MARKET, BY FORM (2016-2028)
TABLE 043. EYE HEALTH INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 044. SOUTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY TYPE (2016-2028)
TABLE 045. SOUTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY APPLICATION (2016-2028)
TABLE 046. SOUTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY SOURCE (2016-2028)
TABLE 047. SOUTH AMERICA EYE HEALTH INGREDIENTS MARKET, BY FORM (2016-2028)
TABLE 048. EYE HEALTH INGREDIENTS MARKET, BY COUNTRY (2016-2028)
TABLE 049. ALLIED BIOTECH CORPORATION: SNAPSHOT
TABLE 050. ALLIED BIOTECH CORPORATION: BUSINESS PERFORMANCE
TABLE 051. ALLIED BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 052. ALLIED BIOTECH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. EFAMOL: SNAPSHOT
TABLE 053. EFAMOL: BUSINESS PERFORMANCE
TABLE 054. EFAMOL: PRODUCT PORTFOLIO
TABLE 055. EFAMOL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. MACUSHIELD: SNAPSHOT
TABLE 056. MACUSHIELD: BUSINESS PERFORMANCE
TABLE 057. MACUSHIELD: PRODUCT PORTFOLIO
TABLE 058. MACUSHIELD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. BASF SE: SNAPSHOT
TABLE 059. BASF SE: BUSINESS PERFORMANCE
TABLE 060. BASF SE: PRODUCT PORTFOLIO
TABLE 061. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. AIDP INC.: SNAPSHOT
TABLE 062. AIDP INC.: BUSINESS PERFORMANCE
TABLE 063. AIDP INC.: PRODUCT PORTFOLIO
TABLE 064. AIDP INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. BI NUTRACEUTICALS: SNAPSHOT
TABLE 065. BI NUTRACEUTICALS: BUSINESS PERFORMANCE
TABLE 066. BI NUTRACEUTICALS: PRODUCT PORTFOLIO
TABLE 067. BI NUTRACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. BLUE CALIFORNIA: SNAPSHOT
TABLE 068. BLUE CALIFORNIA: BUSINESS PERFORMANCE
TABLE 069. BLUE CALIFORNIA: PRODUCT PORTFOLIO
TABLE 070. BLUE CALIFORNIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. AMWAY: SNAPSHOT
TABLE 071. AMWAY: BUSINESS PERFORMANCE
TABLE 072. AMWAY: PRODUCT PORTFOLIO
TABLE 073. AMWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. DSM: SNAPSHOT
TABLE 074. DSM: BUSINESS PERFORMANCE
TABLE 075. DSM: PRODUCT PORTFOLIO
TABLE 076. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ALCON: SNAPSHOT
TABLE 077. ALCON: BUSINESS PERFORMANCE
TABLE 078. ALCON: PRODUCT PORTFOLIO
TABLE 079. ALCON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. SOLGAR: SNAPSHOT
TABLE 080. SOLGAR: BUSINESS PERFORMANCE
TABLE 081. SOLGAR: PRODUCT PORTFOLIO
TABLE 082. SOLGAR: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. SWANSON: SNAPSHOT
TABLE 083. SWANSON: BUSINESS PERFORMANCE
TABLE 084. SWANSON: PRODUCT PORTFOLIO
TABLE 085. SWANSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 086. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 087. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 088. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EYE HEALTH INGREDIENTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EYE HEALTH INGREDIENTS MARKET OVERVIEW BY TYPE
FIGURE 012. BETA CAROTENE MARKET OVERVIEW (2016-2028)
FIGURE 013. VITAMIN A MARKET OVERVIEW (2016-2028)
FIGURE 014. LUTEIN MARKET OVERVIEW (2016-2028)
FIGURE 015. ZEAXANTHIN MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. EYE HEALTH INGREDIENTS MARKET OVERVIEW BY APPLICATION
FIGURE 018. HUMAN MARKET OVERVIEW (2016-2028)
FIGURE 019. ANIMAL MARKET OVERVIEW (2016-2028)
FIGURE 020. EYE HEALTH INGREDIENTS MARKET OVERVIEW BY SOURCE
FIGURE 021. NATURAL MARKET OVERVIEW (2016-2028)
FIGURE 022. SYNTHETIC MARKET OVERVIEW (2016-2028)
FIGURE 023. EYE HEALTH INGREDIENTS MARKET OVERVIEW BY FORM
FIGURE 024. SOFT GEL MARKET OVERVIEW (2016-2028)
FIGURE 025. CAPSULE & TABLETS MARKET OVERVIEW (2016-2028)
FIGURE 026. LIQUID MARKET OVERVIEW (2016-2028)
FIGURE 027. POWDER MARKET OVERVIEW (2016-2028)
FIGURE 028. NORTH AMERICA EYE HEALTH INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. EUROPE EYE HEALTH INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. ASIA PACIFIC EYE HEALTH INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. MIDDLE EAST & AFRICA EYE HEALTH INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. SOUTH AMERICA EYE HEALTH INGREDIENTS MARKET OVERVIEW BY COUNTRY (2016-2028)